2. NF-κB Immunology/Inflammation Apoptosis
  3. Keap1-Nrf2 NO Synthase TNF Receptor Interleukin Related
  4. 4,5-Dehydro-6-oxoallosecurinine

4,5-Dehydro-6-oxoallosecurinine is a Keap1-Nrf2 pathway activator. 4,5-Dehydro-6-oxoallosecurinine promotes the nuclear translocation of Keap1-Nrf2, and induces the expression of antioxidant and cytoprotective genes. 4,5-Dehydro-6-oxoallosecurinine reduces the production of NO, and decreases the levels of iNOS, TNF-α, IL-6 and IL-1β in LPS-stimulated microglia. 4,5-Dehydro-6-oxoallosecurinine can be used for the research of neurodegenerative diseases.

For research use only. We do not sell to patients.

4,5-Dehydro-6-oxoallosecurinine

4,5-Dehydro-6-oxoallosecurinine Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

4,5-Dehydro-6-oxoallosecurinine Related Antibodies

Top Publications Citing Use of Products

View All NO Synthase Isoform Specific Products:

View All Isoforms
nNOS iNOS eNOS

View All TNF Receptor Isoform Specific Products:

View All Isoforms
TNFRSF1A/CD120a TNFRSF3/CD18 TNFRSF4 TNFRSF5/CD40 TNFRSF6/Fas/CD95 TNFRSF7/CD27 TNFRSF8/CD30 TNFRSF9/4-1BB/CD137 TNFRSF10B/DR5/CD262 TNFRSF12A/TWEAK TNFRSF16/NGF Receptor/CD271 TNFRSF18/GITR/CD357

View All Interleukin Related Isoform Specific Products:

View All Isoforms
IL-1 IL-2 IL-3 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-13 IL-15 IL-17 IL-23 IL-7 IL-33 IL-22 IL-18

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

4,5-Dehydro-6-oxoallosecurinine is a Keap1-Nrf2 pathway activator. 4,5-Dehydro-6-oxoallosecurinine promotes the nuclear translocation of Keap1-Nrf2, and induces the expression of antioxidant and cytoprotective genes. 4,5-Dehydro-6-oxoallosecurinine reduces the production of NO, and decreases the levels of iNOS, TNF-α, IL-6 and IL-1β in LPS-stimulated microglia. 4,5-Dehydro-6-oxoallosecurinine can be used for the research of neurodegenerative diseases[1].

In Vitro

4,5-Dehydro-6-oxoallosecurinine (Compound 7) (0.01-10 μM; 6 h) potently activates the nuclear translocation of Keap1-Nrf2 in genetically engineered U2OS cells, with an EC50 of 697.8 nM[1].
4,5-Dehydro-6-oxoallosecurinine (0.01-1 μM; 3 h) induces concentration-dependent nuclear translocation and whole-cell accumulation of Nrf2 in BV-2 microglia after 3 h of treatment[1].
4,5-Dehydro-6-oxoallosecurinine (0.1-1 μM; 6 h) induces concentration-dependent upregulation of Nrf2-dependent antioxidant and cytoprotective genes in BV-2 microglia[1].
Treatment of BV-2 microglial cells with 4,5-Dehydro-6-oxoallosecurinine (0.01-1 μM) for 12 h induces concentration-dependent upregulation of the Nrf2-dependent antioxidant proteins HO-1 and GCLM[1].
4,5-Dehydro-6-oxoallosecurinine (pretreatment for 6 h followed by LPS stimulation for 24 h, 0.03-1 μM) inhibits nitric oxide production in LPS-activated BV-2 microglia[1].
4,5-Dehydro-6-oxoallosecurinine (0.03-1 μM; pre-incubated for 6 h prior to LPS stimulation) concentration-dependently inhibits LPS-induced iNOS mRNA and protein expression in BV-2 microglia[1].
4,5-Dehydro-6-oxoallosecurinine (pre-incubated for 6 h followed by LPS stimulation) concentration-dependently inhibits the mRNA and protein expression of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) in LPS-induced BV-2 microglia[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

4,5-Dehydro-6-oxoallosecurinine Related Antibodies

Western Blot Analysis[1]

Cell Line: BV-2 microglial cells
Concentration: 0.01, 0.03, 0.1, 0.3, 1, 3, and 10 μM
Incubation Time: 3 h
Result: Induced concentration-dependent accumulation of Nrf2 protein in nuclear fractions, with significant increases (relative to vehicle control) observed at 0.3 μM and 1 μM (8- and 4-fold increases, respectively).
Induced concentration-dependent accumulation of Nrf2 protein in whole-cell lysates, with significant increases at 0.1, 0.3, and 1 μM (2-, 3-, and 8-fold increases, respectively).

Real Time qPCR[1]

Cell Line: BV-2 microglial cells
Concentration: 0.1, 0.3, 1 μM
Incubation Time: 6 h
Result: Induced concentration-dependent upregulation of all tested Nrf2 target genes: Hmox1 (1.5-, 2.5-, 6-fold increases, respectively), Gclm (1.2-, 2-, 3.2-fold increases, respectively), Gclc (1.1-, 1.5-, 1.8-fold increases, respectively), Nqo1 (1.5-, 2.5-, 5.5-fold increases, respectively), Osgin1 (1.1-, 1.5-, 2.2-fold increases, respectively), Srxn1 (1.2-, 2-, 3.5-fold increases, respectively), Slc7a11 (1.5-, 3.5-, 7-fold increases, respectively), and Txnrd1 (0.8-, 1.3-, 2.5-fold increases, respectively).
Showed statistically significant increases from 0.1 or 0.3 μM relative to vehicle control.

Western Blot Analysis[1]

Cell Line: BV-2 microglial cells
Concentration: 0.01, 0.03, 0.1, 0.3, 1, 3, and 10 μM
Incubation Time: 12 h
Result: Induced concentration-dependent increases in HO-1 and GCLM protein levels.
Increased HO-1 protein levels significantly at 0.3 μM and 1 μM (3- and 5-fold increases, respectively, relative to vehicle control).
Increased GCLM protein levels significantly at 0.3 μM and 1 μM (3.5- and 8.5-fold increases, respectively, relative to vehicle control).
Molecular Weight

229.23

Formula

C13H11NO3
SMILES

O=C1C=C2C=C[C@H]3N4C(C=CC[C@@]4([H])[C@@]2(C3)O1)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

4,5-Dehydro-6-oxoallosecurinine Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

4,5-Dehydro-6-oxoallosecurinineKeap1-Nrf2NO SynthaseTNF ReceptorInterleukin RelatedNitric oxide synthasesNOSTumor Necrosis Factor ReceptorTNFRILU2OS cellsKeap1-Nrf2 pathway activatorBV-2 microglianeurodegenerative diseasesInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
4,5-Dehydro-6-oxoallosecurinine
Cat. No.:
HY-181818
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.